Surrogate gene therapy for muscular dystrophy
An engineered truncated gene derived from the dystrophin-related protein (utrophin), prevents pathology without an immune response in an animal model of Duchenne muscular dystrophy (DMD) gene therapy.
Príomhchruthaitheoirí: | Davies, KE, Chamberlain, JS |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
Springer Nature
2019
|
Míreanna comhchosúla
-
Therapeutic approaches to muscular dystrophy.
de réir: Goyenvalle, A, et al.
Foilsithe / Cruthaithe: (2011) -
The Pathogenesis and Therapy of Muscular Dystrophies
de réir: Guiraud, S, et al.
Foilsithe / Cruthaithe: (2015) -
Progress in therapy for Duchenne muscular dystrophy.
de réir: Fairclough, R, et al.
Foilsithe / Cruthaithe: (2011) -
Progress in therapy for Duchenne muscular dystrophy
de réir: Fairclough, R, et al.
Foilsithe / Cruthaithe: (2011) -
Utrophin in the therapy of Duchenne Muscular Dystrophy
de réir: Potter, A, et al.
Foilsithe / Cruthaithe: (2006)